Abstract:Abstract Background and aims: Inflammatory microenvironment plays a critical role in promoting hepatocellular carcinoma (HCC) progression. Among the factors secreted by cancer-associated inflammatory cells, tumor necrosis factor-alpha (TNF-α) has been identified as a master regulator of inflammation and a potential mediator in inflammation-related cancers. Forkhead box M1 (FoxM1) is a key cell cycle regulator of the transition from the G1 to the S phase and the progression to mitosis. We previously reported that FoxM1 promotes metastasis and indicates poor prognosis in HCC. However, the critical regulatory mechanism linking TNF-α to FoxM1 activation in inflammation-induced HCC progression remains unclear. In this study, we aim to investigate the mechanism by which FoxM1 is regulated by TNF-α, and the potential role of FoxM1 in inflammation-associated HCC. Methods: Luciferase reporter, chromatin immunoprecipitation, and electrophoretic mobility shift assays were used to measure the transcriptional regulation of FoxM1 promoter by TNF-α. The clinical significance of TNF-α/ROS/HIF-1/FoxM1 pathway in a cohort of 406 HCC patients who underwent curative resection was assessed by Kaplan-Meier analysis and Multivariate Cox proportional hazards model. Results: TNF-α induced FoxM1 expression and transactivated its promoter activity in hepatoma cells. Serial 5′ deletion and site-directed mutagenesis revealed that the induction of FoxM1 expression by TNF-α was dependent upon the HIF1-1 and HIF1-3/4 binding sites within the FoxM1 promoter. Furthermore, at the transcriptional level, the stabilization of HIF-1α via reactive oxygen species (ROS) generation led to the binding of HIF-1α to the FoxM1 promoter and resulted in increased FoxM1 expression. The inhibition of both HIF-1α expression and ROS generation significantly decreased TNF-α-induced FoxM1 expression. Consequently, the upregulation of FoxM1 promoted the proliferation of hepatoma cells and enhanced their resistance to TNF-α-induced apoptosis, whereas downregulation of FoxM1 dramatically attenuated these effects. TNF-α expression was positively correlated with HIF-1α and FoxM1 expression in human HCC tissues. Patients with positive coexpression of TNF-α and FoxM1 had shorter overall survival and higher recurrence rates than those with negative coexpression of TNF-α and FoxM1. Simarily, patients with HIF-1(+)/FoxM1(+) expression had shorter overall survival and higher recurrence rates than those with HIF-1(-)/FoxM1(-) expression. Conclusions: We report a new molecular mechanism by which FoxM1 expression is regulated by the TNF-α/ROS/HIF-1 pathway, and this mechanism results in the proliferation of hepatoma cells and their resistance to apoptosis. Thus, TNF-α/ROS/HIF-1/FoxM1 pathway may provide a target for clinical intervention in HCC. Citation Format: Limin Xia, Daiming Fan, Yongzhan Nie, Kaichun Wu. The TNF-α/ROS/HIF-1-mediated upregulation of FoxM1 expression promotes proliferation, resistance to apoptosis and indicates poor prognosis in hepatocellular carcinoma. [abstract]. In: Proceedings of the 104th Annual Meeting of the American Association for Cancer Research; 2013 Apr 6-10; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2013;73(8 Suppl):Abstract nr 2862. doi:10.1158/1538-7445.AM2013-2862 Note: This abstract was not presented at the AACR Annual Meeting 2013 because the presenter was unable to attend.

Abstract 2053: Overexpressed Rab1A is Associated Poor Prognosis and Promotes Oncogenic Growth and Metastasis Through Mtorc1 Activation in Hepatocellular Carcinoma

Aberrant amino acid signaling promotes growth and metastasis of hepatocellular carcinomas through Rab1A-dependent activation of mTORC1 by Rab1A

RCC1 functions as a tumor facilitator in clear cell renal cell carcinoma by dysregulating cell cycle, apoptosis, and EZH2 stability

Abstract 1029: Rab1A and Rab1B Promote Esophageal Squamous Cell Carcinoma Through Activating Mtorc1 Signaling and Inhibiting Autophagy

Lipophagy-related Gene RAB7A is Involved in Immune Regulation and Malignant Progression in Hepatocellular Carcinoma.

RAB10 Overexpression Promotes Tumor Growth and Indicates Poor Prognosis of Hepatocellular Carcinoma.

Rab1A Promotes Proliferation and Migration Abilities Via Regulation of the HER2/AKT-independent Mtor/s6k1 Pathway in Colorectal Cancer.

Oncogene TUBA1C Promotes Migration and Proliferation in Hepatocellular Carcinoma and Predicts a Poor Prognosis.

Rpn10 promotes tumor progression by regulating hypoxia-inducible factor 1 alpha through the PTEN/Akt signaling pathway in hepatocellular carcinoma.

BUB1B promotes hepatocellular carcinoma progression via activation of the mTORC1 signaling pathway

Rab1A is an Mtorc1 Activator and a Colorectal Oncogene.

Rab11a Regulates MMP2 Expression by Activating the PI3K/AKT Pathway in Human Hepatocellular Carcinoma Cells.

O-GLCNACYLATION ON RAB3A ATTENUATES ITS EFFECTS ON MITOCHONDRIAL OXIDATIVE PHOSPHORYLATION AND METASTASIS IN HEPATOCELLULAR CARCINOMA

Ras Homolog Family Member F, Filopodia Associated Promotes Hepatocellular Carcinoma Metastasis by Altering the Metabolic Status of Cancer Cells Through RAB3D

The Prognostic Biomarker RAB7A Promotes Growth and Metastasis of Liver Cancer Cells by Regulating Glycolysis and YAP1 Activation

Abstract 2862: The TNF-α/ROS/HIF-1-mediated upregulation of FoxM1 expression promotes proliferation, resistance to apoptosis and indicates poor prognosis in hepatocellular carcinoma.

A Novel Hepatocellular Carcinoma-Specific Mtorc1-Related Signature for Anticipating Prognosis and Immunotherapy

Abstract 4389: TSC1/2 Mutations Define a Molecular Subset of HCC with Aggressive Behavior and Treatment Implication

A functional mammalian target of rapamycin complex 1 signaling is indispensable for c‐Myc‐driven hepatocarcinogenesis

RAB42 overexpression correlates with poor prognosis, immune cell infiltration and chemoresistance

Characterization of prognostic value and immunological roles of RAB22A in hepatocellular carcinoma